AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

The New York Times Company

$72.45 +$2.63 (+3.77%)
NYSE · 15 Sep 2026 16:41 UTC
Previous Close
$70.34
Day Range
$70.53$72.62
Year Range
$54.1$87.1
Market Cap
11.77B
AVG Volume
1.94M
Trailing/Forward PE
29.94/23.34
PEG ratio
3.16
Dividend Yield
1.13%
Next Earnings Date
2026-11-04
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q22.98B
26 Q12.9B
25 Q42.82B
25 Q32.75B
25 Q22.69B
25 Q12.63B
24 Q42.59B
24 Q32.54B
24 Q22.49B
24 Q12.46B
Net Income (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2392.82M
26 Q1382.35M
25 Q4343.98M
25 Q3337.87M
25 Q2320.36M
25 Q1302.96M
24 Q4293.82M
24 Q3279.98M
24 Q2269.45M
24 Q1250.48M
Operating Income (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2484.99M
26 Q1473.53M
25 Q4435.95M
25 Q3416.61M
25 Q2388.55M
25 Q1361.41M
24 Q4351.1M
24 Q3333.49M
24 Q2320.33M
24 Q1296.69M
EBITDA (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2615.4M
26 Q1578.83M
25 Q4545.11M
25 Q3532.63M
25 Q2511.18M
25 Q1485.55M
24 Q4476.46M
24 Q3461.3M
24 Q2447M
24 Q1422.45M
Cash Flows (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2623.02M
26 Q1542.17M
25 Q4550.5M
25 Q3536.52M
25 Q2455.24M
25 Q1424.54M
24 Q4381.34M
24 Q3368.09M
24 Q2348.21M
24 Q1339.86M
EPS (USD) · TTM
012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q22.4
26 Q12.33
25 Q42.09
25 Q32.05
25 Q21.94
25 Q11.84
24 Q41.78
24 Q31.69
24 Q21.62
24 Q11.5
Expenses (USD) · TTM
0500M1B1.5BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q21.08B
26 Q11.06B
25 Q4986.19M
25 Q3960.15M
25 Q2889.79M
25 Q1871.82M
24 Q4863.73M
24 Q3845.84M
24 Q2837.82M
24 Q1825.16M
Shares Outstanding (USD) · TTM
-100M0100M200MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYT Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-13.61M
26 Q1-23.25M
25 Q4-18.72M
25 Q3-46.58M
25 Q255.84M
25 Q142.55M
24 Q417.54M
24 Q3-4.64M
24 Q2-17.92M
24 Q1-10.81M
Dividends (USD)
00.10.20.3Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
NYT Dividends (USD) by quarter
PeriodDividends (USD)
Jul 260.23
Apr 260.23
Jan 260.18
Oct 250.18
Jul 250.18
Apr 250.18
Jan 250.13
Oct 240.13
Jul 240.13
Apr 240.13
Employee Count
02K4K6K2016201720182019202020212022202320242025
NYT Employee Count by quarter
PeriodEmployee Count
20256K
20245.9K
20235.9K
20225.8K
20215K
20204.7K
20194.5K
20184.32K
20173.79K
20163.71K
PE Ratio
2530354045med 30.83Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NYT PE Ratio by quarter
PeriodPE Ratio
Sep 2629.01
Sep 2627.59
Sep 2627.75
Aug 2628.12
Aug 2627.1
Aug 2626.73
Aug 2626.21
Jul 2631.74
Jul 2630.37
Jul 2632.18
Jul 2631.77
Jul 2631.3
Jun 2630.04
Jun 2630.96
Jun 2631.1
Jun 2632.58
May 2631.87
May 2631.77
May 2631.56
May 2633.65
May 2637.18
Apr 2638.2
Apr 2637.54
Apr 2637.31
Apr 2640.47
Mar 2639.1
Mar 2638.24
Mar 2637.45
Mar 2637.99
Feb 2637.68
Feb 2637.63
Feb 2635.19
Feb 2632.86
Jan 2635.37
Jan 2634.87
Jan 2634.49
Jan 2634.29
Jan 2633.69
Dec 2533.85
Dec 2534.16
Dec 2532.8
Dec 2531.24
Nov 2531.12
Nov 2530.93
Nov 2530.85
Nov 2529.6
Oct 2529.06
Oct 2529.07
Oct 2528.65
Oct 2527.87
Oct 2528.36
Sep 2529.67
Sep 2529.78
Sep 2530.04
Sep 2530.07
Aug 2530.51
Aug 2530.48
Aug 2530.67
Aug 2529.31
Aug 2528.27
Jul 2528.45
Jul 2528.81
Jul 2530.25
Jul 2530.88
Jun 2530.06
Jun 2529.46
Jun 2530.07
Jun 2530.18
May 2530.88
May 2529.95
May 2530.25
May 2528.98
May 2529.21
Apr 2528.6
Apr 2527.52
Apr 2527.07
Apr 2526.49
Mar 2527.36
Mar 2527.19
Mar 2527.3
Mar 2527.49
Feb 2526.86
Feb 2528.21
Feb 2529.22
Feb 2528.68
Jan 2531.89
Jan 2531.52
Jan 2530.46
Jan 2529.83
Jan 2531.06
Dec 2431.24
Dec 2431.05
Dec 2432.34
Dec 2433.02
Nov 2431.86
Nov 2431.81
Nov 2430.81
Nov 2433.05
Nov 2434.7
Oct 2433.85
Free Cash Flow Yield
3%4%5%6%7%med 4.63%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NYT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 265.47%
Sep 265.75%
Sep 265.71%
Aug 265.64%
Aug 265.85%
Aug 265.93%
Aug 266.05%
Jul 264.47%
Jul 264.67%
Jul 264.41%
Jul 264.46%
Jul 264.53%
Jun 264.72%
Jun 264.58%
Jun 264.56%
Jun 264.35%
May 264.45%
May 264.46%
May 264.49%
May 264.21%
May 264.3%
Apr 264.19%
Apr 264.26%
Apr 264.29%
Apr 263.95%
Mar 264.09%
Mar 264.19%
Mar 264.27%
Mar 264.21%
Feb 264.25%
Feb 264.22%
Feb 264.51%
Feb 264.83%
Jan 264.49%
Jan 264.55%
Jan 264.6%
Jan 264.63%
Jan 264.71%
Dec 254.69%
Dec 254.65%
Dec 254.84%
Dec 255.08%
Nov 255.1%
Nov 255.13%
Nov 255.15%
Nov 255.36%
Oct 254.89%
Oct 254.89%
Oct 254.96%
Oct 255.1%
Oct 255.01%
Sep 254.79%
Sep 254.77%
Sep 254.73%
Sep 254.72%
Aug 254.66%
Aug 254.66%
Aug 254.63%
Aug 254.85%
Aug 254.96%
Jul 254.93%
Jul 254.86%
Jul 254.63%
Jul 254.54%
Jun 254.66%
Jun 254.76%
Jun 254.66%
Jun 254.64%
May 254.54%
May 254.68%
May 254.63%
May 254.84%
May 254.44%
Apr 254.54%
Apr 254.72%
Apr 254.79%
Apr 254.9%
Mar 254.74%
Mar 254.77%
Mar 254.75%
Mar 254.72%
Feb 254.83%
Feb 254.66%
Feb 254.5%
Feb 254.58%
Jan 254.12%
Jan 254.17%
Jan 254.32%
Jan 254.41%
Jan 254.23%
Dec 244.21%
Dec 244.23%
Dec 244.07%
Dec 243.98%
Nov 244.13%
Nov 244.13%
Nov 244.27%
Nov 243.98%
Nov 243.72%
Oct 243.82%
Price to Sales
33.544.55med 3.61Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NYT Price to Sales by quarter
PeriodPrice to Sales
Sep 263.83
Sep 263.64
Sep 263.66
Aug 263.71
Aug 263.57
Aug 263.53
Aug 263.46
Jul 264.18
Jul 264
Jul 264.24
Jul 264.19
Jul 264.12
Jun 263.96
Jun 264.08
Jun 264.1
Jun 264.29
May 264.2
May 264.19
May 264.16
May 264.44
May 264.53
Apr 264.65
Apr 264.57
Apr 264.54
Apr 264.93
Mar 264.76
Mar 264.66
Mar 264.56
Mar 264.63
Feb 264.59
Feb 264.62
Feb 264.33
Feb 264.04
Jan 264.35
Jan 264.28
Jan 264.24
Jan 264.21
Jan 264.14
Dec 254.16
Dec 254.2
Dec 254.03
Dec 253.84
Nov 253.82
Nov 253.8
Nov 253.79
Nov 253.64
Oct 253.46
Oct 253.46
Oct 253.41
Oct 253.32
Oct 253.38
Sep 253.54
Sep 253.55
Sep 253.58
Sep 253.58
Aug 253.64
Aug 253.63
Aug 253.65
Aug 253.49
Aug 253.26
Jul 253.28
Jul 253.32
Jul 253.49
Jul 253.56
Jun 253.47
Jun 253.4
Jun 253.47
Jun 253.48
May 253.56
May 253.45
May 253.49
May 253.34
May 253.32
Apr 253.25
Apr 253.13
Apr 253.08
Apr 253.01
Mar 253.11
Mar 253.09
Mar 253.1
Mar 253.12
Feb 253.05
Feb 253.11
Feb 253.23
Feb 253.17
Jan 253.52
Jan 253.48
Jan 253.36
Jan 253.29
Jan 253.43
Dec 243.45
Dec 243.43
Dec 243.57
Dec 243.65
Nov 243.52
Nov 243.51
Nov 243.4
Nov 243.65
Nov 243.75
Oct 243.66
EV/EBITDA
1517.52022.525med 18.06Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NYT EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2617.45
Sep 2616.54
Sep 2616.64
Aug 2616.87
Aug 2616.22
Aug 2615.99
Aug 2615.66
Jul 2619.94
Jul 2619.03
Jul 2620.23
Jul 2619.96
Jul 2619.65
Jun 2618.82
Jun 2619.43
Jun 2619.52
Jun 2620.5
May 2620.03
May 2619.96
May 2619.82
May 2621.2
May 2622.37
Apr 2623.02
Apr 2622.6
Apr 2622.46
Apr 2624.45
Mar 2623.58
Mar 2623.04
Mar 2622.55
Mar 2622.88
Feb 2622.69
Feb 2622.71
Feb 2621.17
Feb 2619.69
Jan 2621.28
Jan 2620.96
Jan 2620.72
Jan 2620.59
Jan 2620.21
Dec 2520.31
Dec 2520.51
Dec 2519.64
Dec 2518.66
Nov 2518.58
Nov 2518.46
Nov 2518.41
Nov 2517.62
Oct 2517.15
Oct 2517.16
Oct 2516.9
Oct 2516.41
Oct 2516.72
Sep 2517.54
Sep 2517.61
Sep 2517.77
Sep 2517.79
Aug 2518.06
Aug 2518.05
Aug 2518.17
Aug 2517.31
Aug 2516.56
Jul 2516.67
Jul 2516.9
Jul 2517.8
Jul 2518.19
Jun 2517.68
Jun 2517.3
Jun 2517.69
Jun 2517.75
May 2518.19
May 2517.61
May 2517.8
May 2517
May 2516.91
Apr 2516.53
Apr 2515.86
Apr 2515.59
Apr 2515.23
Mar 2515.76
Mar 2515.66
Mar 2515.73
Mar 2515.84
Feb 2515.45
Feb 2516.05
Feb 2516.66
Feb 2516.34
Jan 2518.29
Jan 2518.06
Jan 2517.42
Jan 2517.04
Jan 2517.78
Dec 2417.89
Dec 2417.78
Dec 2418.56
Dec 2418.97
Nov 2418.27
Nov 2418.24
Nov 2417.63
Nov 2418.99
Nov 2420
Oct 2419.48
Price/Operating Cashflow
1517.52022.525med 20.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NYT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2617.31
Sep 2616.46
Sep 2616.56
Aug 2616.78
Aug 2616.17
Aug 2615.95
Aug 2615.64
Jul 2621.01
Jul 2620.1
Jul 2621.3
Jul 2621.03
Jul 2620.72
Jun 2619.88
Jun 2620.49
Jun 2620.58
Jun 2621.57
May 2621.1
May 2621.03
May 2620.89
May 2622.28
May 2621.88
Apr 2622.48
Apr 2622.09
Apr 2621.96
Apr 2623.82
Mar 2623.01
Mar 2622.5
Mar 2622.04
Mar 2622.36
Feb 2622.18
Feb 2622.23
Feb 2620.79
Feb 2619.41
Jan 2620.89
Jan 2620.59
Jan 2620.37
Jan 2620.25
Jan 2619.9
Dec 2519.99
Dec 2520.17
Dec 2519.37
Dec 2518.45
Nov 2518.38
Nov 2518.27
Nov 2518.22
Nov 2517.48
Oct 2519
Oct 2519.01
Oct 2518.73
Oct 2518.22
Oct 2518.55
Sep 2519.4
Sep 2519.47
Sep 2519.65
Sep 2519.67
Aug 2519.95
Aug 2519.93
Aug 2520.06
Aug 2519.17
Aug 2518.76
Jul 2518.88
Jul 2519.12
Jul 2520.08
Jul 2520.49
Jun 2519.95
Jun 2519.55
Jun 2519.95
Jun 2520.03
May 2520.49
May 2519.88
May 2520.07
May 2519.23
May 2520.91
Apr 2520.47
Apr 2519.69
Apr 2519.38
Apr 2518.96
Mar 2519.58
Mar 2519.46
Mar 2519.54
Mar 2519.67
Feb 2519.22
Feb 2519.98
Feb 2520.69
Feb 2520.31
Jan 2522.58
Jan 2522.33
Jan 2521.57
Jan 2521.13
Jan 2522
Dec 2422.12
Dec 2421.99
Dec 2422.9
Dec 2423.39
Nov 2422.57
Nov 2422.53
Nov 2421.82
Nov 2423.41
Nov 2424.99
Oct 2424.38
Price to Book
4567med 5.04Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NYT Price to Book by quarter
PeriodPrice to Book
Sep 265.57
Sep 265.29
Sep 265.32
Aug 265.39
Aug 265.2
Aug 265.13
Aug 265.03
Jul 266.06
Jul 265.8
Jul 266.15
Jul 266.07
Jul 265.98
Jun 265.74
Jun 265.91
Jun 265.94
Jun 266.22
May 266.09
May 266.07
May 266.03
May 266.43
May 266.26
Apr 266.44
Apr 266.32
Apr 266.29
Apr 266.82
Mar 266.59
Mar 266.44
Mar 266.31
Mar 266.4
Feb 266.35
Feb 266.42
Feb 266
Feb 265.61
Jan 266.04
Jan 265.95
Jan 265.89
Jan 265.85
Jan 265.75
Dec 255.78
Dec 255.83
Dec 255.6
Dec 255.33
Nov 255.31
Nov 255.28
Nov 255.26
Nov 255.05
Oct 254.81
Oct 254.81
Oct 254.74
Oct 254.61
Oct 254.69
Sep 254.91
Sep 254.93
Sep 254.97
Sep 254.98
Aug 255.05
Aug 255.04
Aug 255.08
Aug 254.85
Aug 254.54
Jul 254.57
Jul 254.63
Jul 254.86
Jul 254.96
Jun 254.83
Jun 254.73
Jun 254.83
Jun 254.85
May 254.96
May 254.81
May 254.86
May 254.66
May 254.45
Apr 254.36
Apr 254.2
Apr 254.13
Apr 254.04
Mar 254.17
Mar 254.15
Mar 254.16
Mar 254.19
Feb 254.09
Feb 254.26
Feb 254.42
Feb 254.34
Jan 254.82
Jan 254.77
Jan 254.6
Jan 254.51
Jan 254.7
Dec 244.72
Dec 244.69
Dec 244.89
Dec 244.99
Nov 244.82
Nov 244.81
Nov 244.66
Nov 245
Nov 245.18
Oct 245.05
The New York Times Company
NYT
Stockpicker

Video analysis: NYT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NYT

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More

247wallst.com · 15 Sep 2026

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More

Markets are rattled ahead of Wednesday's Fed decision, and Wall Street analysts are making bold moves on names like Eli Lilly, Etsy, Northrop Grumman, and Rivian. Find out which stocks got upgraded, downgraded, or newly covered before the opening bell.

OS Therapies Announces Full Alignment with UK MHRA and EU EMA for Conditional Marketing Authorisation Application Filing

newsfilecorp.com · 15 Sep 2026

OS Therapies Announces Full Alignment with UK MHRA and EU EMA for Conditional Marketing Authorisation Application Filing

Overall Survival (OS) historical-control data gains HMRA and EMA support for pending CMAA submissions Full alignment achieved on confirmatory Phase 3 trial design Complete CMAA submission expected in coming weeks New York, New York and Rockville, Maryland--(Newsfile Corp. - September 15, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or the "Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has achieved full alignment with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) on its pending Conditional Marketing Authorisation Application (CMAA). MHRA agreed that the use of comparable historical control data – derived from a systematic evaluation of all suitable available peer-reviewed literature by independent biostatistics advisors presented in its most recent Scientific Advice Meeting (SAM) - was appropriate in the orphan indication Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma.

TOMMY HILFIGER Presents “Plaza Prep” at New York Fashion Week

businesswire.com · 10 Sep 2026

TOMMY HILFIGER Presents “Plaza Prep” at New York Fashion Week

AMSTERDAM--(BUSINESS WIRE)--Tommy Hilfiger, which is part of PVH Corp. [NYSE: PVH], staged a personal New York celebration today, presenting Spring 2027 at The Plaza Hotel. The legendary address — where Tommy Hilfiger once lived with his family — became the ultimate backdrop for modern prep, as uptown tradition and downtown cool passed through the same revolving doors. “For 40 years, I've been inspired by the style of New Yorkers — how the people of the city take the classics and make them thei.

DOJ probes Nvidia's licensing deal with AI startup Groq, NYT reports

reuters.com · 9 Sep 2026

DOJ probes Nvidia's licensing deal with AI startup Groq, NYT reports

The U.S. Justice Department is investigating whether ​Nvidia tried to skirt antitrust scrutiny ‌of the chipmaker's licensing deal last year with AI chip startup Groq, the New York ​Times reported on Wednesday, citing ​two people familiar with the matter.

The New York Times Company (NYT) Presents at Citi's 2026 Global TMT Conference Transcript

seekingalpha.com · 9 Sep 2026

The New York Times Company (NYT) Presents at Citi's 2026 Global TMT Conference Transcript

The New York Times Company (NYT) Presents at Citi's 2026 Global TMT Conference Transcript

Concurrent Investment Advisors LLC Makes New $2.56 Million Investment in The New York Times Company $NYT

defenseworld.net · 9 Sep 2026

Concurrent Investment Advisors LLC Makes New $2.56 Million Investment in The New York Times Company $NYT

Concurrent Investment Advisors LLC acquired a new position in shares of The New York Times Company (NYSE: NYT) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 36,655 shares of the company's stock, valued at approximately $2,565,000. Other institutional

US government sides with OpenAI in New York Times copyright lawsuit

techxplore.com · 3 Sep 2026

US government sides with OpenAI in New York Times copyright lawsuit

U.S. President Donald Trump's administration sided with OpenAI in a lawsuit brought by The New York Times, defending training AI models on copyrighted works, according to a court document filed Tuesday.

The Untold Story ‘NEW YORK IN MONCLER'

businesswire.com · 3 Sep 2026

The Untold Story ‘NEW YORK IN MONCLER'

NEW YORK--(BUSINESS WIRE)-- #AlpineInTheCity--The untold story of New York in Moncler began when snow met concrete. What could have melted instead endured, forging a love built on pioneering moments and strengthened with every chapter. They found each other, again and again. Decades later, their story is finally ready to be shared. Revealed through one of the largest open-air public exhibitions the city has ever seen, New York in Moncler unveils the peak moments that capture the bond between New York and Moncler,.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.